ロード中...
uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
BACKGROUND: While increased urokinase-type plasminogen activator (uPA) expression in breast cancer tissue is directly associated with poor prognosis, recent evidence suggests that uPA overexpression may suppress tumor growth and prolong survival. Celecoxib has been shown to have antiangiogenic and a...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2580770/ https://ncbi.nlm.nih.gov/pubmed/18922176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-298 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|